TECH logo

TECH Bio-Techne Corporation

NASDAQ · Biotechnology · Healthcare

$72.40
+0.23 (+0.32%)

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspe…

Market Cap: $11.34Bwww.bio-techne.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

107
100102104107
Aug 12Aug 13

Quote

Day Range
$72.06 – $72.42
52-Week Range
$43.20 – $72.43
Volume
$2.00M
Market Cap
$11.34B
50-Day Avg
$66.93
200-Day Avg
$60.10
Prev Close
$72.17
Open
$72.18

Valuation & Ratios

P/E Ratio
60.38
EPS
$1.17
P/B Ratio
5.17
P/S Ratio
9.07
Debt/Equity
0.14
Current Ratio
4.55
Dividend Yield
+0.5%
Gross Margin
+65.8%

Returns & Efficiency

Return on Equity
+8.5%
Return on Assets
+7.0%
FCF Yield
+2.4%
EV/EBITDA
32.15

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2026$1.22B$181.86M$1.17
2025$1.22B$73.40M$0.47
2024$1.16B$168.10M$1.07
2023$1.14B$285.26M$1.81
2022$1.11B$272.05M$1.73

Social Signal Score

56
5d
56
6 mentions
30d
55
6 mentions
60d
55
6 mentions
90d
55
6 mentions
news: 6

Earnings

Wed, Nov 4(in 3 months)

Consensus estimate $0.46 per share

5of 7 quarters beat consensus

Typical surprise +6.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Aug 12$0.52 vs $0.52beat
  • Wed, May 6$0.53 vs $0.55miss
  • Wed, Feb 4$0.46 vs $0.43beat
  • Wed, Nov 5$0.42 vs $0.42miss
  • Wed, Aug 6$0.53 vs $0.50beat
  • Wed, May 7$0.56 vs $0.51beat

Estimates and results for TECH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from TECH's reported EPS growth of -9.3% a year over 4 years.

EPS in 5 years
$0.72
Implied price
$12.88
Return from $72.40
-29.2% a year

To earn 15.0% a year on these assumptions you'd need to buy at $6.41 -91.2% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1215182124
-19.3%-41.9%-39.3%-37.0%-35.0%-33.3%
-14.3%-38.3%-35.5%-33.1%-31.0%-29.1%
-9.3%-34.7%-31.7%-29.2%-27.0%-25.0%
-4.3%-31.1%-28.0%-25.3%-23.0%-20.9%
0.7%-27.5%-24.2%-21.4%-18.9%-16.7%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (6)

  • Newszacks.com·2d ago·Positive

    TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.

    View source ↗
  • Newsprnewswire.com·2d ago·Neutral

    Bio-Techne Corrects Dividend Announcement MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026.

    View source ↗
  • Newsglobenewswire.com·2d ago·Neutral

    CMB.TECH ANNOUNCES Q2 2026 RESULTS ON 27/08/2026 ANTWERP, Belgium, 13 August 2026 – CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMBT”, “CMB.TECH” or “the Company”) will release its second quarter 2026 earnings prior to market opening on Thursday 27 August 2026 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. The half year report will be published on 3 September 2026.

    View source ↗
  • Newszacks.com·3d ago·Neutral

    Techne (TECH) Q4 Earnings Meet Estimates Techne (TECH) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.53 per share a year ago.

    View source ↗
  • Newsprnewswire.com·3d ago·Neutral

    Bio-Techne Declares Dividend MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026.

    View source ↗
  • Newsprnewswire.com·3d ago·Neutral

    Bio-Techne Releases Fourth Quarter Fiscal 2026 Results MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million.

    View source ↗